https://twitter.com/cov19treatments/status/139947920332679... https://files.catbox.moe/k2miut.pdf

Health Canada authorized the COVID-19 vaccines without biodistribution and pharmacokinetic studies on the virus spike protein. Given the concerns about the spike protein, it is important that we fully understand:
• which cells are actually involved in the production of the spike protein, seeing that Pfizer’s own study submitted to the Japanese authorities shows the deposition of vaccine nanoparticles in various tissues and organs;
• whether the spike protein is gaining access to the circulatory system and, if so, for how long;
• whether the spike protein crosses the blood-brain barrier;
• whether the spike protein interferes with semen production or ovulation,
• whether the spike protein crosses the placenta and impacts a developing baby, or
• whether the spike protein is excreted in the milk of lactating mothers.
The same information is needed for the S1 subunit of the spike protein, which is the part that binds to ACE2 receptors; and which has also been detected in the plasma of individuals following mRNA-1273 (Moderna) vaccination (Ogata et al., 2021).

Доказательная медицина, COVID-19, ЗОЖ